Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

TMEM132E Antikörper

TMEM132E Reaktivität: Maus WB Wirt: Kaninchen Polyclonal unconjugated
Produktnummer ABIN1112940
  • Target Alle TMEM132E Antikörper anzeigen
    TMEM132E (Transmembrane Protein 132E (TMEM132E))
    Reaktivität
    • 14
    • 10
    • 1
    Maus
    Wirt
    • 16
    Kaninchen
    Klonalität
    • 16
    Polyklonal
    Konjugat
    • 6
    • 2
    • 2
    • 2
    • 2
    • 2
    Dieser TMEM132E Antikörper ist unkonjugiert
    Applikation
    • 16
    • 13
    • 12
    Western Blotting (WB)
    Aufreinigung
    affinity purified
    Isotyp
    IgG
    Top Product
    Discover our top product TMEM132E Primärantikörper
  • Applikationshinweise
    WB (1:500). Other applications have not been tested. The optimal dilutions should be determined by end user.
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Liquid
    Buffer
    TBS (pH7.4), 0.5% BSA, 40% Glycerol and 0.05% Sodium Azide.
    Konservierungsmittel
    Sodium azide, Thimerosal (Merthiolate)
    Lagerung
    4 °C/-20 °C
    Informationen zur Lagerung
    Store at 4 °C after thawing (1 week). Aliquot and store at -20 °C for long term (at least one year). Avoid repeated freeze and thaw cycles.
    Haltbarkeit
    12 months
  • Target
    TMEM132E (Transmembrane Protein 132E (TMEM132E))
    Andere Bezeichnung
    Transmembrane protein 132E, TMEM132E (TMEM132E Produkte)
    Synonyme
    Gm644 antikoerper, transmembrane protein 132E antikoerper, TMEM132E antikoerper, Tmem132e antikoerper
    Hintergrund
    Transmembrane protein 132E (TMEM132E) also known as HSPA5-binding protein 1, is a member of the TMEM132 family, which composed of TMEM132A, -B, -C, -D, -E. It is located in a region involved in a heterozygous deletion of approximately 4.7 Mb, this deletion, involving the NF1 gene and contiguous genes lying in its flanking regions, is observed in a patient 17q11.2 microdeletion syndrome, a syndrome characterized by variable facial dysmorphism, mental retardation, developmental delay, and an excessive number of neurofibromas.
Sie sind hier:
Kundenservice